LATEST FROM IPOX^®

News

News and updates from IPOX^®, including media mentions, interviews, research and press releases.

Media mentions · Reuters

Reuters: IPOX^® Associate Lukas Muehlbauer Comments on Kardigan’s IPO and Biotech Market Recovery

IPOX^® Associate Lukas Muehlbauer was cited by Reuters on Kardigan’s planned U.S. IPO, which targets a valuation of up to $1.4 billion and aims to raise as much as $373.3 million. Muehlbauer noted a “clear uptick in biotech IPOs” and said healthcare IPO activity has already surpassed last year’s deal flow, signaling an open window for the sector. He also cautioned that investors remain selective, favoring companies with clinical progress and clearer paths to FDA approval.

June 12, 2026Lukas Muehlbauer

Media mentions · ZEIT ONLINE

ZEIT ONLINE: IPOX^® Associate Lukas Muehlbauer Discusses Market Absorption Risks Around Mega IPOs

IPOX^® Associate Muehlbauer was interviewed for ZEIT ONLINE, the digital news platform of the German weekly newspaper DIE ZEIT, on the market impact of major planned IPOs and new share offerings. He discussed SpaceX’s expected $75 billion raise, possible listings from leading AI companies, and the challenge of absorbing significant new equity supply. He also noted that later insider sales may be the more important liquidity test for investors after the initial IPO.

June 12, 2026Lukas Muehlbauer

Media mentions · Reuters

Reuters: IPOX^® Associate Muehlbauer Comments on ERock’s NYSE Debut and Valuation

IPOX^® Associate Dr. Lukas Muehlbauer was quoted by Reuters on ERock’s NYSE debut after the gas generator maker’s shares opened below their IPO price, valuing the company at $5.49 billion. Muehlbauer said investors were pushing back on valuation amid execution risk, noting that ERock’s growth angle is tied to a substantial backlog from data center power demand, but the market wants proof that backlog can convert into revenue before assigning the company a more premium public-market valuation after its listing.

June 10, 2026

Media mentions · Bloomberg

Bloomberg: IPOX^® CEO Josef Schuster Discusses the Golden Age of IPOs

Bloomberg featured IPOX^® Founder and CEO Josef Schuster in an interview with Matt Miller on “Bloomberg Deals,” titled “The Golden Age of IPOs is Here: IPOX^®’s Schuster.” The segment discussed SpaceX’s planned IPO, expected to raise about $75 billion and rank as the largest IPO ever. Schuster joined the program to provide IPOX^®’s perspective on the broader IPO market and the current wave of major listings.

June 10, 2026Josef Schuster

Media mentions · Reuters

Reuters: IPOX^® Associate Muehlbauer Comments on Parabilis Medicines’ Upsized US IPO

IPOX^® Associate Lukas Muehlbauer was quoted by Reuters on Parabilis Medicines’ upsized U.S. IPO, which targets a valuation of nearly $2.3 billion as biotech listings regain momentum. Muehlbauer said the larger offering signals a healthier biotech IPO pipeline, while noting investors remain selective and favor larger, better-backed deals. He also highlighted Parabilis’ Regeneron partnership as an external validation of the company’s technology and a source of added credibility ahead of its expected Nasdaq debut under ticker PBLS.

June 9, 2026

Media mentions · Reuters

Reuters: IPOX^® CEO Josef Schuster Comments on OpenAI’s IPO Filing and AI Listing Trends

IPOX^® CEO Josef Schuster was featured in Reuters’ View article on OpenAI’s confidential U.S. IPO filing, which examined how major AI companies are moving toward public markets. Schuster commented that SpaceX, OpenAI, and Anthropic are seeking public-market capital to finance significant growth, while noting that investors may both reward and punish these companies as their fundamentals develop. He also highlighted that their offering size and initial float could make post-listing trading highly dynamic over time for investors and markets alike.

June 9, 2026Josef Schuster

Media mentions · Nikkei

Nikkei: IPOX^® CEO Josef Schuster Comments on SpaceX’s Mega IPO and Broader Market Implications

IPOX^® CEO Josef Schuster featured in Japan's largest business paper Nikkei on SpaceX’s planned mega IPO and its potential market impact. The article examines whether an offering of unprecedented scale could temporarily absorb capital, increase stock-specific volatility, and affect index rebalancing, while also attracting new investment over the longer term. Schuster noted that large IPOs can heighten individual-stock volatility and potentially ripple across broader markets, but that investors have limited precedent for an equity debut of this magnitude so far.

June 5, 2026Josef Schuster

Media mentions · Reuters

Reuters: IPOX^® Associate Lukas Muehlbauer Comments on Innio’s Nasdaq Debut and AI Infrastructure Demand

IPOX^® Research Associate Lukas Muehlbauer commented on Innio’s Nasdaq debut in Reuters coverage of the gas engine maker’s upsized $2.43 billion IPO. Muehlbauer said the market backdrop is supportive for companies building the physical backbone of AI, as investors reward businesses tied to data-center power demand. He noted Innio’s established GE heritage and said the company must show equipment order growth can continue and translate into long-term service revenue for data centers requiring reliable power and maintenance over time globally.

June 4, 2026Lukas Muehlbauer

Media mentions · Reuters

Reuters: IPOX^® VP Kat Liu Comments on Quantinuum’s Nasdaq Debut and Quantum Computing Market Trends

IPOX^® VP Kat Liu commented on Quantinuum’s Nasdaq debut in Reuters coverage of the Honeywell-backed quantum computing company’s upsized IPO. Liu said the investment case centers on quantum computing’s long-term role in future infrastructure, supported by its strategic relevance to national security, AI, communications and advanced computing. She also noted Quantinuum’s Honeywell backing and expansion into software, cybersecurity and quantum networking, while cautioning that commercial adoption remains limited and investors remain focused on the sector’s long-term opportunity.

June 4, 2026Kat Liu

News

Stay ahead of the next listing.